Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy.
about
MicroRNA 329 suppresses angiogenesis by targeting CD146The matricellular protein cysteine-rich protein 61 (CCN1/Cyr61) enhances physiological adaptation of retinal vessels and reduces pathological neovascularization associated with ischemic retinopathyPolyunsaturated fatty acid metabolism in prostate cancerMicrovascular repair: post-angiogenesis vascular dynamicsHIF-1alpha and HIF-2alpha are differentially activated in distinct cell populations in retinal ischaemiaDiscovery of novel orally active anti-inflammatory N-phenylpyrazolyl-N-glycinyl-hydrazone derivatives that inhibit TNF-α productionRetinal ganglion cell death is induced by microglia derived pro-inflammatory cytokines in the hypoxic neonatal retinaN-CAM exhibits a regulatory function in pathological angiogenesis in oxygen induced retinopathyDifferential modulation of angiogenesis by erythropoiesis-stimulating agents in a mouse model of ischaemic retinopathyThe mouse retina as an angiogenesis model.Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesisNeuronal and glial cell changes are determined by retinal vascularization in retinopathy of prematurity.Genetic and pharmacological inhibition of JNK ameliorates hypoxia-induced retinopathy through interference with VEGF expression.Reduced nitro-oxidative stress and neural cell death suggests a protective role for microglial cells in TNFalpha-/- mice in ischemic retinopathy.Hypoxia and the expression of HIF-1alpha and HIF-2alpha in the retina of streptozotocin-injected mice and ratsNAD(P)H oxidase-dependent regulation of CCL2 production during retinal inflammation.The alternative complement pathway regulates pathological angiogenesis in the retinaStudies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis)Exploitation of the nicotinic anti-inflammatory pathway for the treatment of epithelial inflammatory diseases.Inflammation and retinopathy of prematurity.Endoglin promotes angiogenesis in cell- and animal-based models of retinal neovascularization.The absence of LPA receptor 2 reduces the tumorigenesis by ApcMin mutation in the intestine.Macrophage metalloelastase (MMP-12) deficiency mitigates retinal inflammation and pathological angiogenesis in ischemic retinopathy.Hyperoxia causes regression of vitreous neovascularization by downregulating VEGF/VEGFR2 pathway.Double anti-angiogenic and anti-inflammatory protein Valpha targeting VEGF-A and TNF-alpha in retinopathy and psoriasis.A low-oxygenated subpopulation of pancreatic islets constitutes a functional reserve of endocrine cells.Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse modelTNF-alpha is critical for ischemia-induced leukostasis, but not retinal neovascularization nor VEGF-induced leakageIncreased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesisThe alternative complement pathway aids in vascular regression during the early stages of a murine model of proliferative retinopathyPhenotype-based Discovery of 2-[(E)-2-(Quinolin-2-yl)vinyl]phenol as a Novel Regulator of Ocular Angiogenesis.Nuclear receptor RORα regulates pathologic retinal angiogenesis by modulating SOCS3-dependent inflammation.MEF2C ablation in endothelial cells reduces retinal vessel loss and suppresses pathologic retinal neovascularization in oxygen-induced retinopathyeNOS overexpression exacerbates vascular closure in the obliterative phase of OIR and increases angiogenic drive in the subsequent proliferative stageEndogenous erythropoietin protects neuroretinal function in ischemic retinopathy.Functional analyses of TNFR2 in physiological and pathological retina angiogenesis.Molecular targets for retinal vascular diseases.Early retinal inflammatory biomarkers in the middle cerebral artery occlusion model of ischemic stroke.Antiangiogenic and antineuroinflammatory effects of kallistatin through interactions with the canonical Wnt pathway.Adiponectin suppresses pathological microvessel formation in retina through modulation of tumor necrosis factor-alpha expression.
P2860
Q24310981-6474D78F-0BC7-4D21-BA5F-319B57621C55Q24595183-E1E89485-A526-402B-A420-46042D83CABAQ24629893-32F9C55C-D7FC-46FD-9C84-6332613FE65EQ27004093-1C2C7216-2800-44DA-9E9E-404AA1AF8C84Q28474375-26D62E7F-9575-4DE4-BF63-855983517AB7Q28484258-F4A81B71-6BCF-4443-8EB1-D6F21F832B8FQ28564803-1122A033-75F4-48CE-B5B6-6B68832F1388Q28743741-C8BA6D80-FDDB-4478-A736-FEFC4AA13B69Q28750073-A7747A30-15C0-4572-ADDC-93D135A1AC0CQ30495106-17FC233C-7032-4D22-8DDB-3BA794DC5E39Q30542079-D61E65DC-F022-4183-9042-88A680F8D17FQ33292414-9618C436-0BAE-4AD6-885D-E53E0FC59A4DQ33443692-A2404D03-B8E8-40D0-8186-AB14144F5696Q33526952-B323AAE9-6F0D-4A26-9EC5-7ED10C0F3F03Q33665353-DFA3F093-0961-4833-8AA2-AD8EB88C42FDQ33676913-383BB68F-ABA1-418E-944D-A526440EC5B2Q33775122-85F79BE0-0544-4972-86AA-43173E10DA9AQ33787955-0293CCA9-4F3F-4504-B682-00BC05678601Q33866877-99693C75-8C58-4464-9D26-01116740EEC8Q33987848-0DB448FC-FF7F-4B7C-8FF6-728A5BD33D7CQ34341837-CD2339B6-3114-4984-B413-0D2E02FE4C60Q34357465-FD017F42-2CFD-441A-8BD8-E327C87732A1Q34534458-9FF3C883-8F02-48A2-B781-7CBE425F37E6Q34544365-180EC7E7-1CF1-4AC8-8181-D1F0FFFC392FQ34800330-C1492EDA-E5E6-4FBC-B80B-FF6AFE067C5AQ35123539-294D7238-A358-4683-91BA-41491BB4ED9BQ35221114-4C66A22D-38C8-47B6-8602-471875D7D162Q35642213-0487538A-0447-4860-BD31-8CCE61E5E585Q35817458-6BC86AFF-611E-4164-BE42-B765FD5CB0E9Q35859558-AE860384-6EEE-43AD-9F26-FFEA40F5CF3DQ35914881-974DBACD-7BAE-4FA2-BAC4-1980567CA6F2Q35989713-F09CB147-4509-4986-96AB-DBC494A65A08Q36044670-9BF43262-0186-4E10-9778-CA7E6883A642Q36302954-88E7C3DD-37D7-41FF-ACEA-E187AD7D2694Q36494891-AD84A424-B26F-45EF-A08E-7030FD858817Q36531084-8AC640E6-86E8-4E1C-9238-294949FECFB5Q36667825-714DBBE8-5CC9-4E10-B063-8D91B254E416Q36968685-84DC28D8-C8AB-4AEF-847F-1425A0AD0EDAQ37333523-7148B179-4F03-41E8-A762-86ABE20B3899Q37339479-A6078443-DB05-48C2-957A-CDB3BC4CA667
P2860
Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Inhibition of tumor necrosis f ...... ation in ischemic retinopathy.
@en
type
label
Inhibition of tumor necrosis f ...... ation in ischemic retinopathy.
@en
prefLabel
Inhibition of tumor necrosis f ...... ation in ischemic retinopathy.
@en
P2093
P2860
P1476
Inhibition of tumor necrosis f ...... zation in ischemic retinopathy
@en
P2093
Denise M McDonald
Tanyth E de Gooyer
Tom A Gardiner
Vidal F de la Cruz
P2860
P304
P356
10.1016/S0002-9440(10)62284-5
P407
P577
2005-02-01T00:00:00Z